Jazz Pharma officer plans sale of 2,000 shares

Jazz Pharmaceuticals plc (JAZZ) received a notice that officer Renee D. Gala plans to sell up to 2,000 shares of the company’s common stock under Rule 144.

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc (JAZZ) received a notice that officer Renee D. Gala plans to sell up to 2,000 shares of the company’s common stock under Rule 144. The shares, described as Restricted Stock, were acquired on June 30, 2026 and are to be sold through Morgan Stanley Smith Barney LLC, with a stated aggregate market value of $486,060 as of September 8, 2026.

Key Figures

Shares to be sold: 2,000 shares Aggregate market value: $486,060 Acquisition date of shares: June 30, 2026 +2 more

5 metrics

Shares to be sold 2,000 shares Maximum Jazz Pharmaceuticals common shares listed under Rule 144 for sale by officer Renee D. Gala

Aggregate market value $486,060 Value associated with the 2,000 common shares as of September 8, 2026

Acquisition date of shares June 30, 2026 Date the restricted stock to be sold was acquired

Sale reference date September 8, 2026 Date tied to market value and sale information for the 2,000 shares

Trading market NASDAQ Listed market for Jazz Pharmaceuticals common stock covered by the notice

Key Terms

Rule 144, Restricted Stock, common stock, NASDAQ

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 06/30/2026 | Restricted Stock | ISSUER"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

common stock financial

"Common | Morgan Stanley Smith Barney LLC Executive Financial Services"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

NASDAQ market

"64914577 | 09/08/2026 | NASDAQ"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

What does the Form 144 filing for JAZZ by Renee D. Gala disclose?

It discloses that Renee D. Gala, an officer of Jazz Pharmaceuticals, plans to sell up to 2,000 shares of common stock under Rule 144. The filing lists the shares as Restricted Stock to be sold through Morgan Stanley Smith Barney LLC.

How many Jazz Pharmaceuticals (JAZZ) shares are covered by this Rule 144 notice?

The notice covers up to 2,000 shares of Jazz Pharmaceuticals common stock. These shares are identified as Restricted Stock and are the amount indicated in the securities information and securities-to-be-sold sections of the filing.

What is the indicated market value of the JAZZ shares in this Form 144?

The filing shows an aggregate market value of $486,060 for the 2,000 shares of Jazz Pharmaceuticals common stock listed for potential sale, based on information as of September 8, 2026.

When were the Jazz Pharmaceuticals (JAZZ) shares acquired and when are they to be sold?

The shares are reported as acquired on June 30, 2026 and are listed for potential sale with a reference date of September 8, 2026. Both dates appear in the securities information and securities-to-be-sold sections.

Which broker is handling the planned Rule 144 sale for JAZZ shares?

The planned sale is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza. This broker is named in the securities information section for the 2,000 shares of Jazz Pharmaceuticals common stock.

On which market are the Jazz Pharmaceuticals (JAZZ) shares in this Form 144 traded?

The filing identifies the trading market as NASDAQ for the common stock of Jazz Pharmaceuticals associated with this Rule 144 notice covering 2,000 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:38 PM Accepted by SEC EDGAR 09/08/2026 - 04:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001607737
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
SEC File Number	001-33500
Address of Issuer	Fifth Floor, Waterloo Exchange Waterloo Road Dublin 4 IRELAND D04 E5W7
Phone	011-353-1-634-7800
Name of Person for Whose Account the Securities are To Be Sold	RENEE D GALA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2000	486060.00	64914577	09/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/30/2026	Restricted Stock	ISSUER			2000	06/30/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Renee Gala
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)